Literature DB >> 7611423

Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells.

P Singh-Kaw1, R Zarnegar, J M Siegfried.   

Abstract

We examined the mitogenic, chemoinvasive, and chemotactic effects of hepatocyte growth factor (HGF) toward normal and neoplastic human epithelial cells derived from the bronchial mucosa. Primary cultures of human bronchial epithelial cells (HBE cells), immortalized bronchial epithelial cells (IB3-1 cells), and cells derived from a squamous cell carcinoma of the lung (128-88T cells) were used as targets. HGF was mitogenic for all three cell types as measured by bromodeoxyuridine (BrdU) labeling and colony-forming efficiency (CFE). With the use of BrdU labeling, 9.8-16.8% of nuclei were labeled in controls vs. 56.9-65.6% labeled nuclei in cells treated with HGF. HGF stimulated colony formation 3.6-6.2-fold over untreated control. Analysis by reverse transcription-polymerase chain reaction demonstrated the presence of the c-met gene, the receptor for HGF, in all three cell types. Cell lysates from all three cell types contained proteins that were recognized by a c-met antibody as determined by Western blotting. The gene for HGF was not expressed in any of the cell types, although it was expressed in control MRC5 fibroblasts. No HGF protein could be detected by Western blotting in the conditioned medium from epithelial cells, although it was readily detectable in medium conditioned by lung fibroblasts. HGF proved to be a powerful chemotactic agent for all three cell types and also stimulated invasion into Matrigel, an artificial basement membrane. The results indicate HGF acts mainly as a paracrine growth factor for cells derived from the human bronchus, and may play a role in the growth and progression of lung tumors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611423     DOI: 10.1152/ajplung.1995.268.6.L1012

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility.

Authors:  O Sakamoto; A Iwama; R Amitani; T Takehara; N Yamaguchi; T Yamamoto; K Masuyama; T Yamanaka; M Ando; T Suda
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 2.  Therapeutic targeting of acute lung injury and acute respiratory distress syndrome.

Authors:  Theodore J Standiford; Peter A Ward
Journal:  Transl Res       Date:  2015-05-05       Impact factor: 7.012

Review 3.  Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis.

Authors:  M Jeffers; S Rong; G F Vande Woude
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

Review 4.  Hepatocyte growth factor/scatter factor-induced intracellular signalling.

Authors:  K A Stuart; S M Riordan; S Lidder; L Crostella; R Williams; G G Skouteris
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

Review 5.  Hepatocyte growth factor in lung repair and pulmonary fibrosis.

Authors:  Ronald Allan M Panganiban; Regina M Day
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

6.  Syndecan-1 Attenuates Lung Injury during Influenza Infection by Potentiating c-Met Signaling to Suppress Epithelial Apoptosis.

Authors:  Rena Brauer; Lingyin Ge; Saundra Y Schlesinger; Timothy P Birkland; Ying Huang; Tanyalak Parimon; Vivian Lee; Bonnie L McKinney; John K McGuire; William C Parks; Peter Chen
Journal:  Am J Respir Crit Care Med       Date:  2016-08-01       Impact factor: 21.405

7.  Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells.

Authors:  Taofeek K Owonikoko; Suresh S Ramalingam; Beatriz Kanterewicz; Trent E Balius; Chandra P Belani; Pamela A Hershberger
Journal:  Int J Cancer       Date:  2010-02-01       Impact factor: 7.396

8.  Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis.

Authors:  Laura P Stabile; Mary E Rothstein; Phouthone Keohavong; Jide Jin; Jinling Yin; Stephanie R Land; Sanja Dacic; The Minh Luong; K Jin Kim; Austin M Dulak; Jill M Siegfried
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

9.  Hepatocyte growth factor regulates cyclooxygenase-2 expression via beta-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells.

Authors:  Young H Lee; Yuichiro J Suzuki; Autumn J Griffin; Regina M Day
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-02-01       Impact factor: 5.464

10.  GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcoma.

Authors:  Manish Charan; Piyush Dravid; Maren Cam; Anthony Audino; Amy C Gross; Michael A Arnold; Ryan D Roberts; Timothy P Cripe; Alexander Pertsemlidis; Peter J Houghton; Hakan Cam
Journal:  Int J Cancer       Date:  2019-11-06       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.